Constitutive activity of NF-kappa B in myeloid cells drives pathogenicity of monocytes and macrophages during autoimmune neuroinflammation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Journal of Neuroinflammation 9.15 (2012)
- Schlagwort
-
-
Immunologie
Immunsystem
Lymphozyt
Leukozyt
Immunität
Resistenz
Immunchemie
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2012
- Beteiligte Personen und Organisationen
- URN
-
urn:nbn:de:bvb:29-opus-35743
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ellrichmann, Gisa
- Thöne, Jan
- Lee, De-Hyung
- Rupec, Rudolph A.
- Gold, Ralf
- Linker, Ralf A.
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2012
Ähnliche Objekte (12)
Constitutive activity of NF-kappa B in myeloid cells drives pathogenicity of monocytes and macrophages during autoimmune neuroinflammation
Dietary fatty acids and susceptibility to multiple sclerosis
Multiple Sklerose - zwischen Grundlagenforschung und klinischer Anwendung
Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study
Navigating choice in multiple sclerosis management
Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy
Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation
Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation
Peripheral CD19+ B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders
The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis
Krankheitsmodifizierende Therapie der sekundär progredienten Multiplen Sklerose
Management of Immune-Mediated Paraneoplastic Neurological Disorders
Constitutive activity of NF-kappa B in myeloid cells drives pathogenicity of monocytes and macrophages during autoimmune neuroinflammation
Dietary fatty acids and susceptibility to multiple sclerosis
Multiple Sklerose - zwischen Grundlagenforschung und klinischer Anwendung
Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study
Navigating choice in multiple sclerosis management
Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy
Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation
Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation
Peripheral CD19+ B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders
The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis
Krankheitsmodifizierende Therapie der sekundär progredienten Multiplen Sklerose
Management of Immune-Mediated Paraneoplastic Neurological Disorders
Constitutive activity of NF-kappa B in myeloid cells drives pathogenicity of monocytes and macrophages during autoimmune neuroinflammation
Dietary fatty acids and susceptibility to multiple sclerosis
Multiple Sklerose - zwischen Grundlagenforschung und klinischer Anwendung
Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study
Navigating choice in multiple sclerosis management
Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy
Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation
Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation
Peripheral CD19+ B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders
The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis
Krankheitsmodifizierende Therapie der sekundär progredienten Multiplen Sklerose